This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Innovations by Wei Ni
Introduction
Wei Ni is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on neuregulin compounds. With a total of 2 patents, his innovations are paving the way for new treatment methods.
Latest Patents
Wei Ni's latest patents include "Neuregulin-4 compounds and methods of use." This invention relates to neuregulin (NRG) 4 compounds and outlines methods of treatment utilizing these compounds. His work in this area is crucial for advancing therapeutic options.
Career Highlights
Wei Ni is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His role at the company allows him to contribute to groundbreaking advancements in medicine.
Collaborations
Throughout his career, Wei Ni has collaborated with notable colleagues, including James David Pancook and Avinash Muppidi. These partnerships enhance the research and development process, leading to more effective solutions in the pharmaceutical industry.
Conclusion
Wei Ni's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of new treatment methods, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile